{
    "2020-11-15": [
        [
            {
                "time": "",
                "original_text": "【浙商医药|周报】估值持续回落，mRNA疫苗积极结果导致板块分化",
                "features": {
                    "keywords": [
                        "估值回落",
                        "mRNA疫苗",
                        "积极结果",
                        "板块分化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药行业每周医览药闻：中国科技创新的卖水者 科学服务行业方兴未艾",
                "features": {
                    "keywords": [
                        "医药行业",
                        "科技创新",
                        "科学服务",
                        "方兴未艾"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "科学服务"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "生物医药行业周报：辉瑞新冠疫苗保护率超90% 新冠疫苗研发稳定推进",
                "features": {
                    "keywords": [
                        "生物医药",
                        "辉瑞",
                        "新冠疫苗",
                        "保护率",
                        "研发推进"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}